Table 3:
Sleep Wake Time, Midpoint and Associated Metabolites by Pathway1
Metabolite | Wake Time | Sleep Midpoint | ||||||
---|---|---|---|---|---|---|---|---|
Relative change2 | 95% CI3 | P-value | Q-value4 | Relative Change2 | 95% CI3 | P-value | Q-value4 | |
Gamma-glutamyl amino acid | ||||||||
Gamma-glutamylisoleucine | 1.11 | 1.05–1.16 | 0.00014 | 0.036 | 1.14 | 1.06–1.21 | 0.0002 | 0.035 |
Gamma-glutamylphenylalanine | 1.04 | 1.02–1.07 | 0.00038 | 0.036 | 1.06 | 1.03–1.09 | 0.0003 | 0.035 |
Gamma-glutamylleucine | 1.08 | 1.04–1.13 | 0.00037 | 0.036 | 1.10 | 1.05–1.17 | 0.0004 | 0.036 |
Gamma-glutamylvaline | 1.10 | 1.04–1.15 | 0.00054 | 0.040 | 1.13 | 1.06–1.20 | 0.0005 | 0.038 |
Gamma-glutamylalanine | 1.06 | 1.01–1.11 | 0.012 | 0.159 | 1.09 | 1.03–1.16 | 0.0053 | 0.078 |
Gamma-glutamyltyrosine | 1.03 | 1.01–1.05 | 0.0083 | 0.122 | 1.04 | 1.01–1.07 | 0.0057 | 0.078 |
Gamma-glutamylglutamate | 1.17 | 1.05–1.29 | 0.0041 | 0.099 | 1.19 | 1.04–1.36 | 0.0137 | 0.108 |
Phenylalanine and tyrosine metabolism | ||||||||
N-acetyltyrosine | 1.02 | 1.00–1.03 | 0.010 | 0.132 | 1.03 | 1.01–1.05 | 0.003 | 0.075 |
N-acetylphenylalanine | 1.02 | 1.01–1.03 | 0.005 | 0.100 | 1.02 | 1.01–1.04 | 0.006 | 0.078 |
3-[3-(sulfooxy)phenyl]propanoic acid | 1.10 | 1.03–1.17 | 0.004 | 0.099 | 1.12 | 1.03–1.22 | 0.009 | 0.095 |
3-methoxytyramine sulfate | 1.02 | 0.98–1.06 | 0.314 | 0.540 | 1.07 | 1.01–1.12 | 0.016 | 0.117 |
Thyroxine | 0.94 | 0.89–0.99 | 0.013 | 0.168 | 0.93 | 0.87–0.99 | 0.022 | 0.134 |
4-hydroxyphenylpyruvate | 0.94 | 0.88–1.00 | 0.056 | 0.314 | 0.91 | 0.83–0.99 | 0.027 | 0.152 |
P-cresol sulfate | 1.03 | 1.00–1.06 | 0.081 | 0.333 | 1.04 | 1.00–1.08 | 0.046 | 0.194 |
Glutamate metabolism | ||||||||
Glutamine | 0.97 | 0.95–0.99 | 0.002 | 0.092 | 0.96 | 0.94–0.99 | 0.008 | 0.088 |
Glutamate | 1.05 | 1.02–1.09 | 0.003 | 0.092 | 1.06 | 1.02–1.11 | 0.009 | 0.100 |
Dipeptide group | ||||||||
N-acetylcarnosine | 1.02 | 1.00–1.05 | 0.021 | 0.213 | 1.04 | 1.01–1.07 | 0.004 | 0.075 |
Isoleucylglycine | 1.03 | 1.01–1.06 | 0.006 | 0.101 | 1.04 | 1.01–1.07 | 0.009 | 0.100 |
Valylleucine | 1.04 | 0.99–1.10 | 0.092 | 0.342 | 1.07 | 1.00–1.14 | 0.039 | 0.183 |
Valylglycine | 1.05 | 0.99–1.10 | 0.096 | 0.344 | 1.07 | 1.00–1.14 | 0.051 | 0.200 |
Pyrimidine metabolism | ||||||||
5-methyluridine (ribothymidine) | 1.01 | 1.00–1.03 | 0.016 | 0.187 | 1.02 | 1.01–1.04 | 0.003 | 0.075 |
Orotidine | 1.02 | 1.01–1.04 | 0.006 | 0.101 | 1.03 | 1.01–1.05 | 0.006 | 0.078 |
Pseudouridine | 1.01 | 1.00–1.02 | 0.068 | 0.319 | 1.02 | 1.00–1.03 | 0.013 | 0.108 |
2’-deoxyuridine | 1.02 | 1.00–1.05 | 0.068 | 0.319 | 1.03 | 1.00–1.07 | 0.050 | 0.200 |
Krebs cycle / TCA cycle | ||||||||
Succinate | 1.03 | 1.01–1.05 | 0.002 | 0.092 | 1.04 | 1.02–1.07 | 0.002 | 0.071 |
Citrate | 0.95 | 0.89–1.01 | 0.117 | 0.379 | 0.92 | 0.84–0.99 | 0.036 | 0.175 |
Alpha-ketoglutarate | 0.96 | 0.92–1.00 | 0.044 | 0.280 | 0.95 | 0.90–1.00 | 0.050 | 0.200 |
Methionine, cysteine, SAM, and taurine metabolism group | ||||||||
Methionine sulfoxide | 1.10 | 1.04–1.16 | 0.001 | 0.043 | 1.12 | 1.04–1.20 | 0.002 | 0.070 |
Methionine sulfone | 1.02 | 1.00–1.04 | 0.052 | 0.302 | 1.03 | 1.01–1.06 | 0.007 | 0.081 |
N-acetyltaurine | 1.03 | 1.01–1.05 | 0.003 | 0.099 | 1.03 | 1.01–1.06 | 0.011 | 0.105 |
Glycolysis, gluconeogenesis, pyruvate metabolism group | ||||||||
1,5-anhydroglucitol (1,5-ag) | 1.02 | 1.01–1.03 | 0.001 | 0.060 | 1.02 | 1.01–1.04 | 0.004 | 0.075 |
Glucuronate | 1.03 | 1.01–1.05 | 0.017 | 0.192 | 1.04 | 1.01–1.07 | 0.005 | 0.075 |
Lysolipid | ||||||||
1-stearoylglycerophosphoinositol | 1.06 | 1.03–1.09 | 0.001 | 0.043 | 1.08 | 1.03–1.12 | 0.001 | 0.040 |
1-oleoylglycerophosphoinositol* | 1.04 | 1.00–1.08 | 0.063 | 0.318 | 1.07 | 1.02–1.13 | 0.012 | 0.108 |
1-palmitoylplasmenylethanolamine* | 1.04 | 1.01–1.07 | 0.019 | 0.201 | 1.05 | 1.01–1.09 | 0.013 | 0.108 |
1-palmitoylglycerophosphoinositol* | 1.07 | 1.02–1.13 | 0.005 | 0.101 | 1.08 | 1.02–1.15 | 0.015 | 0.115 |
1-oleoylplasmenylethanolamine* | 1.05 | 1.01–1.09 | 0.022 | 0.213 | 1.06 | 1.01–1.11 | 0.021 | 0.133 |
1-stearoylglycerophosphoethanolamine | 1.02 | 1.00–1.04 | 0.101 | 0.352 | 1.03 | 1.00–1.06 | 0.035 | 0.175 |
1-stearoylplasmenylethanolamine* | 1.03 | 1.00–1.06 | 0.049 | 0.294 | 1.04 | 1.00–1.08 | 0.036 | 0.175 |
1-arachidonoylglycerophosphoinositol* | 1.01 | 0.99–1.03 | 0.191 | 0.456 | 1.02 | 1.00–1.05 | 0.048 | 0.198 |
Other | ||||||||
Erythrulose (Advance glycation end-product) | 0.96 | 0.94–0.99 | 0.004 | 0.099 | 0.94 | 0.91–0.97 | 0.0002 | 0.035 |
HWESASXX (Polypeptide) | 1.08 | 1.02–1.14 | 0.007 | 0.113 | 1.13 | 1.05–1.21 | 0.001 | 0.049 |
5-Hete (Eicosanoid) | 1.06 | 1.02–1.10 | 0.003 | 0.099 | 1.08 | 1.03–1.13 | 0.002 | 0.075 |
Leukotriene B4 (Eicosanoid) | 1.20 | 1.04–1.39 | 0.014 | 0.175 | 1.32 | 1.09–1.59 | 0.005 | 0.075 |
Prostaglandin E2 (Eicosanoid) | 1.13 | 1.03–1.24 | 0.008 | 0.122 | 1.16 | 1.03–1.31 | 0.013 | 0.108 |
Erythronate (Aminosugar metabolism) * | 1.02 | 1.01–1.03 | 0.003 | 0.099 | 1.02 | 1.00–1.03 | 0.015 | 0.115 |
Tartronate (hydroxymalonate) (Bacterial/fungal) | 1.06 | 1.00–1.12 | 0.042 | 0.274 | 1.09 | 1.01–1.17 | 0.023 | 0.141 |
Myo-inositol (Inositol metabolism) | 1.01 | 1.00–1.03 | 0.030 | 0.248 | 1.02 | 1.00–1.04 | 0.043 | 0.189 |
4-guanidinobutanoate (Guanidino and acetamido metabolism) | 1.08 | 0.99–1.17 | 0.075 | 0.327 | 1.12 | 1.00–1.24 | 0.049 | 0.200 |
Bradykinin, Des-Arg(9)(Polypeptide) | 1.08 | 0.96–1.22 | 0.222 | 0.482 | 1.17 | 1.00–1.37 | 0.051 | 0.200 |
Tocopherol metabolism | ||||||||
Delta-tocopherol | 1.04 | 1.00–1.09 | 0.072 | 0.323 | 1.09 | 1.03–1.15 | 0.005 | 0.078 |
Tryptophan metabolism | ||||||||
Indole-3-carboxylic acid | 1.03 | 1.00–1.06 | 0.034 | 0.250 | 1.05 | 1.01–1.09 | 0.007 | 0.081 |
Kynurenine | 1.01 | 1.00–1.02 | 0.032 | 0.248 | 1.01 | 1.00–1.02 | 0.016 | 0.118 |
Leucine, isoleucine and valine metabolism | ||||||||
Isovalerate5 | 1.12 | 1.06–1.19 | 0.0002 | 0.036 | 1.15 | 1.06–1.24 | 0.001 | 0.047 |
N-acetylvaline | 1.01 | 1.00–1.02 | 0.023 | 0.214 | 1.01 | 1.00–1.03 | 0.013 | 0.108 |
3-methyl-2-oxobutyrate | 0.95 | 0.91–0.99 | 0.018 | 0.196 | 0.94 | 0.89–0.99 | 0.014 | 0.108 |
Isoleucine | 1.01 | 1.00–1.01 | 0.042 | 0.274 | 1.01 | 1.00–1.02 | 0.041 | 0.184 |
N-acetylisoleucine | 1.02 | 1.00–1.03 | 0.064 | 0.318 | 1.02 | 1.00–1.04 | 0.041 | 0.184 |
Fatty acid metabolism group | ||||||||
Butyrylcarnitine | 0.96 | 0.93–0.99 | 0.017 | 0.196 | 0.95 | 0.91–0.99 | 0.013 | 0.108 |
Palmitoylcarnitine (C16) | 0.96 | 0.93–0.99 | 0.018 | 0.196 | 0.96 | 0.92–1.01 | 0.114 | 0.266 |
Alanine and aspartate metabolism | ||||||||
N-acetylalanine | 1.01 | 1.00–1.02 | 0.006 | 0.103 | 1.01 | 1.00–1.02 | 0.006 | 0.078 |
Fatty acid, monohydroxy | ||||||||
13-Hode + 9-Hode | 1.10 | 1.03–1.18 | 0.004 | 0.099 | 1.14 | 1.05–1.24 | 0.004 | 0.075 |
Drug | ||||||||
4-acetylphenol sulfate | 1.05 | 1.00–1.10 | 0.035 | 0.250 | 1.08 | 1.01–1.14 | 0.023 | 0.141 |
2-acetamidophenol sulfate | 1.06 | 0.99–1.13 | 0.089 | 0.342 | 1.09 | 1.01–1.19 | 0.040 | 0.184 |
Benzoate metabolism | ||||||||
4-ethylphenylsulfate | 1.05 | 1.02–1.09 | 0.006 | 0.101 | 1.06 | 1.01–1.11 | 0.021 | 0.133 |
Catechol sulfate | 1.03 | 1.00–1.07 | 0.048 | 0.294 | 1.05 | 1.01–1.09 | 0.027 | 0.154 |
O-methylcatechol sulfate | 1.03 | 1.00–1.07 | 0.085 | 0.339 | 1.05 | 1.00–1.10 | 0.045 | 0.192 |
Lysine metabolism | ||||||||
N6-acetyllysine | 1.01 | 1.00–1.02 | 0.056 | 0.314 | 1.02 | 1.00–1.03 | 0.021 | 0.133 |
Glutarylcarnitine (C5) | 0.99 | 0.99–1.00 | 0.166 | 0.429 | 0.99 | 0.98–1.00 | 0.045 | 0.192 |
Monoacylglycerol | ||||||||
1-myristoylglycerol (1-monomyristin) | 1.03 | 1.00–1.06 | 0.024 | 0.217 | 1.05 | 1.02–1.09 | 0.005 | 0.075 |
Pentose metabolism group | ||||||||
Ribitol | 1.02 | 1.01–1.03 | 0.002 | 0.092 | 1.03 | 1.01–1.04 | 0.003 | 0.075 |
Purine metabolism group | ||||||||
N6-succinyladenosine | 1.02 | 1.00–1.03 | 0.006 | 0.101 | 1.02 | 1.00–1.03 | 0.029 | 0.156 |
7-methylguanine | 1.01 | 1.00–1.02 | 0.078 | 0.331 | 1.02 | 1.00–1.03 | 0.010 | 0.104 |
N2,N2-dimethylguanosine | 1.01 | 1.00–1.02 | 0.036 | 0.250 | 1.02 | 1.00–1.03 | 0.013 | 0.108 |
Food component/plant | ||||||||
Saccharin | 0.93 | 0.86–1.01 | 0.106 | 0.360 | 0.88 | 0.78–0.98 | 0.025 | 0.145 |
2-oxindole-3-acetate | 1.05 | 0.99–1.11 | 0.104 | 0.357 | 1.09 | 1.01–1.17 | 0.028 | 0.156 |
Ergothioneine | 0.93 | 0.88–0.98 | 0.014 | 0.171 | 0.94 | 0.87–1.01 | 0.073 | 0.231 |
Glycine, serine and threonine metabolism | ||||||||
N-acetylthreonine | 1.01 | 1.00–1.03 | 0.090 | 0.342 | 1.02 | 1.00–1.05 | 0.037 | 0.180 |
N-acetylserine | . | . | . | . | 1.01 | 1.00–1.02 | 0.045 | 0.192 |
Long chain fatty acid | ||||||||
Cis-vaccenate (18:1n7) | 0.98 | 0.97–1.00 | 0.062 | 0.318 | 0.97 | 0.95–0.99 | 0.015 | 0.113 |
Myristoleate (14:1N5) | 0.98 | 0.96–1.00 | 0.063 | 0.318 | 0.97 | 0.94–1.00 | 0.029 | 0.156 |
Xanthine metabolism | ||||||||
3,7-dimethylurate | 1.04 | 0.98–1.11 | 0.193 | 0.456 | 1.10 | 1.02–1.19 | 0.020 | 0.133 |
Chemical | ||||||||
4-Hydroxychlorothalonil | 1.01 | 1.00–1.02 | 0.094 | 0.342 | 1.02 | 1.00–1.03 | 0.018 | 0.128 |
Fatty acid, dicarboxylate | ||||||||
3-carboxy-4-methyl-5-propyl-2-furanpropanoate (CMPF) | 1.04 | 1.02–1.07 | 0.0003 | 0.036 | 1.06 | 1.03–1.09 | 0.0004 | 0.035 |
Sphingolipid metabolism | ||||||||
Oleoyl sphingomyelin | 1.01 | 1.00–1.02 | 0.094 | 0.342 | 1.02 | 1.00–1.03 | 0.035 | 0.175 |
The relative change and its associated 95% confidence interval, P -value and Q-value were calculated using linear random effect models adjusted for age, sex, race, sodium level, dietary pattern and visit. The table is ranked by p-value of pathway analysis.
The relative change has been exponentiated. The relative change in metabolite per 1-hour increase in sleep variable.
Lower and upper 95% confidence intervals.
Metabolites with a Q-value of ≥ 0.2 for either wake time or sleep mid-point are included.
Result not available.
Isovalerate is classified as both a short chain fatty acid and amino acid